Richard Kurupi

1.1k citations
9 papers · 432 indexed · h-index 9
Topics
Neuroblastoma Research and Treatments (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)HER2/EGFR in Cancer Research (2 papers)
Partner nations
United StatesJapan

In The Last Decade

Richard Kurupi

9 papers receiving 431 citations

Peers

Richard Kurupi
Comparison fields: 5 of 54
  • Molecular Biology 285
  • Cancer Research 151
  • Oncology 143
  • Pulmonary and Respiratory Medicine 114
  • Neurology 67
Replace Anja Kafka with:
Anja Kafka Croatia
Curt J. Essenburg United States
Estelle Daudigeos‐Dubus France
Woody Han United States
L. Adam United States
Tambudzai Shamu United States
Robert Cozens Switzerland
Katelyn N. Nelson United States
Lynn Bjerke United Kingdom
Jason P. Frazier United States
Richard Kurupi relative to Anja Kafka Croatia Anja Kafka's profile →
Citations per field
00.5×1.5×
Anja Kafka · 1×
Citations per year

Countries citing papers authored by Richard Kurupi

Since Specialization
Citations

This map shows the geographic impact of Richard Kurupi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kurupi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kurupi more than expected).

Fields of papers citing papers by Richard Kurupi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Kurupi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kurupi. The network helps show where Richard Kurupi may publish in the future.

Co-authorship network of co-authors of Richard Kurupi

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kurupi. A scholar is included among the top collaborators of Richard Kurupi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kurupi. Richard Kurupi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 10
2 104
3 11
4 13
5 14
6 18
7 68
8 122
9 72

About Richard Kurupi

Richard Kurupi is a scholar working on Neurology, Cancer Research and Oncology, having authored 9 papers that have together received 432 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (151 citations), Oncology (143 citations) and Neurology (67 citations). Richard Kurupi has collaborated with scholars based in United States and Japan. Frequent co-authors include Carlos L. Arteaga, Philip Owens, Mikhail G. Dozmorov, Luis J. Schwarz, Justin M. Balko, Anthony C. Faber, Todd W. Miller, Henry Gómez, Rebecca S. Cook and Neil E. Bhola. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Science Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026